1035235-27-8Relevant articles and documents
Phase Separation Macrocyclization in a Complex Pharmaceutical Setting: Application toward the Synthesis of Vaniprevir
Godin, éric,Bédard, Anne-Catherine,Raymond, Micha?l,Collins, Shawn K.
, p. 7576 - 7582 (2017)
A phase separation/continuous flow strategy employing an oxidative Glaser-Hay coupling of alkynes has been applied toward the synthesis of the macrocyclic core of complex pharmaceutical vaniprevir. The phase separation/continuous flow strategy afforded similar yields at 100-500 times the concentration and at shorter reaction times than common slow addition/high dilution techniques. In addition, dendritic PEG cosolvents were employed in the phase separation strategy for the first time and shown to allow productive macrocyclization at concentrations up to 200 mM.
PI3 KINASE INHIBITORS AND USES THEREOF
-
Paragraph 00137, (2021/10/15)
A compound of the formula (II); a pharmaceutical composition comprising same; and methods for treating a fibrotic disease in a subject.
INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT
-
Paragraph 00423-00424, (2021/12/28)
The present invention relates to compounds of Formula (I) that target the MLH1 and/or PMS2 proteins that are components of the DNA Mismatch Repair (MMR) process: Formula (I) wherein R1, R2, R3, R4, R6